Merck Serono related Press Releases
ABLYNX AND MERCK SERONO EXPAND THEIR PARTNERSHIP INTO OSTEOARTHRITIS
ABLYNX AND MERCK SERONO EXPAND THEIR PARTNERSHIP INTO OSTEOARTHRITIS Wed Nov 9, 2011 1:01am EST GHENT, Belgium, 9 November 2011 - Ablynx [Euronext Brussels: ABLX] today announced that it has further Read more...
BioMarin to Present at the Credit Suisse Healthcare Conference
NOVATO, Calif., Nov. 3, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development at BioMarin, will present a Read more...
Dual-Novel Combinations: A New Strategy for Developing Cancer Drugs
Oliver Wyman paper highlights jump in efficacy, quicker time to market NEW YORK--(BUSINESS WIRE)-- A rarely used—and as yet largely unproven—approach to drug development has emerged as a significant Read more...
BIO-Europe® 2011 workshop to discover which biotech “has talent”
ZURICH & DUESSELDORF, Germany--(BUSINESS WIRE)-- Promising biotechs will have a unique opportunity to pitch their best assets to a star-studded panel of business development executives in a Read more...
Merck Serono and Ono Pharmaceutical Form Collaborations to Develop Oral Multiple Sclerosis Drug and Cancer Immunotherapy
Merck Serono and Ono Pharmaceutical Form Collaborations to Develop Oral Multiple Sclerosis Drug and Cancer Immunotherapy GENEVA, October 4, 2011 /PRNewswire/ -- - Merck Serono to collaborate with Ono Read more...
BioMarin to Host Third Quarter 2011 Financial Results Conference Call and Webcast on Thursday, October 27 at 5:00 p.m. ET
NOVATO, Calif., Sept. 29, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call Read more...
Pharmaron to Host Merck Serono Research and Development Laboratory in China
BEIJING--(BUSINESS WIRE)-- Pharmaron announced a strategic partnership with Merck Serono, the biopharmaceutical division of Merck KGaA, Germany. In the framework of this partnership, Pharmaron’s new Read more...
BioMarin to Present at the Morgan Stanley Global Healthcare Conference
NOVATO, Calif., Sept. 7, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company update at Read more...
Merck Serono and F-Star to Collaborate in the Discovery and Development of Novel Targeted Biologics
GENEVA, Switzerland, September 7, 2011 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a research, license and commercialisation agreement was signed Read more...
BioMarin to Present at the Baird Health Care Conference
NOVATO, Calif., Aug. 30, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey Cooper, Chief Financial Officer of BioMarin, will present a company update at Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
